The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Anna Suk-Fong Lok

Division of Gastroenterology and Hepatology

University of Michigan Health System

University of Michigan

1500 East Medical Center Drive

USA. Electronic address:

[email]@umich.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Gastroenterology and Hepatology, University of Michigan Health System, University of Michigan, 1500 East Medical Center Drive, USA. Electronic address:. 2013
  • Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA. 2000 - 2012
  • University of Michigan Medical Center, Ann Arbor, USA. 2001 - 2002

References

  1. HCV NS5A Inhibitors in Development. Suk-Fong Lok, A. Clin. Liver. Dis (2013) [Pubmed]
  2. Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B. Lok, A.S., Trinh, H., Carosi, G., Akarca, U.S., Gadano, A., Habersetzer, F., Sievert, W., Wong, D., Lovegren, M., Cohen, D., Llamoso, C. Gastroenterology (2012) [Pubmed]
  3. Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Lok, A.S., Everhart, J.E., Di Bisceglie, A.M., Kim, H.Y., Hussain, M., Morgan, T.R. Hepatology (2011) [Pubmed]
  4. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Lok, A.S., Everhart, J.E., Wright, E.C., Di Bisceglie, A.M., Kim, H.Y., Sterling, R.K., Everson, G.T., Lindsay, K.L., Lee, W.M., Bonkovsky, H.L., Dienstag, J.L., Ghany, M.G., Morishima, C., Morgan, T.R. Gastroenterology (2011) [Pubmed]
  5. Drug therapy: tenofovir. Lok, A.S. Hepatology (2010) [Pubmed]
  6. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Lok, A.S., Sterling, R.K., Everhart, J.E., Wright, E.C., Hoefs, J.C., Di Bisceglie, A.M., Morgan, T.R., Kim, H.Y., Lee, W.M., Bonkovsky, H.L., Dienstag, J.L. Gastroenterology (2010) [Pubmed]
  7. Chronic hepatitis B: update 2009. Lok, A.S., McMahon, B.J. Hepatology (2009) [Pubmed]
  8. Hepatitis B: liver fibrosis and hepatocellular carcinoma. Lok, A.S. Gastroenterol. Clin. Biol. (2009) [Pubmed]
  9. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Lok, A.S., Seeff, L.B., Morgan, T.R., di Bisceglie, A.M., Sterling, R.K., Curto, T.M., Everson, G.T., Lindsay, K.L., Lee, W.M., Bonkovsky, H.L., Dienstag, J.L., Ghany, M.G., Morishima, C., Goodman, Z.D. Gastroenterology (2009) [Pubmed]
  10. EASL International Recognition Awardee 2009: Prof. Ding-Shinn Chen. Lok, A.S. J. Hepatol. (2009) [Pubmed]
  11. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Lok, A.S., Zoulim, F., Locarnini, S., Bartholomeusz, A., Ghany, M.G., Pawlotsky, J.M., Liaw, Y.F., Mizokami, M., Kuiken, C. Hepatology (2007) [Pubmed]
  12. Chronic hepatitis B. Lok, A.S., McMahon, B.J. Hepatology (2007) [Pubmed]
  13. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Lok, A.S., Everhart, J.E., Chung, R.T., Padmanabhan, L., Greenson, J.K., Shiffman, M.L., Everson, G.T., Lindsay, K.L., Bonkovsky, H.L., Di Bisceglie, A.M., Lee, W.M., Morgan, T.R., Ghany, M.G., Morishima, C. Clin. Gastroenterol. Hepatol. (2007) [Pubmed]
  14. Navigating the maze of hepatitis B treatments. Lok, A.S. Gastroenterology (2007) [Pubmed]
  15. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Lok, A.S., Ghany, M.G., Goodman, Z.D., Wright, E.C., Everson, G.T., Sterling, R.K., Everhart, J.E., Lindsay, K.L., Bonkovsky, H.L., Di Bisceglie, A.M., Lee, W.M., Morgan, T.R., Dienstag, J.L., Morishima, C. Hepatology (2005) [Pubmed]
  16. Chronic hepatitis B: update of recommendations. Lok, A.S., McMahon, B.J. Hepatology (2004) [Pubmed]
  17. New treatment of chronic hepatitis B. Lok, A.S. Semin. Liver Dis. (2004) [Pubmed]
  18. Prevention of hepatitis B virus-related hepatocellular carcinoma. Lok, A.S. Gastroenterology (2004) [Pubmed]
  19. Prevention of recurrent hepatitis B post-liver transplantation. Lok, A.S. Liver Transpl. (2002) [Pubmed]
  20. Management of hepatitis B: 2000--summary of a workshop. Lok, A.S., Heathcote, E.J., Hoofnagle, J.H. Gastroenterology (2001) [Pubmed]
  21. Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Teo, E.K., Han, S.H., Terrault, N., Luketic, V., Jensen, D., Keeffe, E.B., Lok, A.S. Hepatology (2001) [Pubmed]
  22. Chronic hepatitis B. Lok, A.S., McMahon, B.J. Hepatology (2001) [Pubmed]
  23. Hepatitis B infection: pathogenesis and management. Lok, A.S. J. Hepatol. (2000) [Pubmed]
  24. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Lok, A.S., Hussain, M., Cursano, C., Margotti, M., Gramenzi, A., Grazi, G.L., Jovine, E., Benardi, M., Andreone, P. Hepatology (2000) [Pubmed]
 
WikiGenes - Universities